Pekanbaru, 10 October 2015 - PT Kalbe Farma Tbk. (Kalbe) today holds free healthcare services for Pekanbaru residents. This event is a part of Kalbe Haze Relief Aid that takes place in a number of cities in Indonesia. The event is held at Colour's Mart Panam, and is attended by dr. Fira Septiyani, Chief of Health Department of Pekanbaru City, and Drs.  Syamsu Khair, Chief of Tampan District.

Jakarta, 10 September 2015 – PT Kalbe Farma Tbk. (Kalbe) today holds the conference to the 9 winners of Kalbe Junior Scientist Award 2015 at the Center of Research and Technology Exhibition Center, Taman Mini Indonesia Indah, East Jakarta.  The event is attended by Mr. Dr.  Muhammad Dimyati, M.Sc. Director General Research and Development Reinforcement of the Ministry of Research and Technology and Higher Education of Republic of Indonesia. 

Jakarta, 5 September 2015 – PT Kalbe Farma Tbk (Kalbe) alongside the Stem Cell and Cancer Institute (SCI) today holds the culmination of the series of scientific seminars education program DR. Boenjamin Setiawan Distinguished Lecture Series (DBSDLS) 2015 at Grand Hyatt Hotel, Jakarta. The third year event discusses on the most recent development of cancer management therapy through immunology and immunotherapy. The series of scientific seminars DBSDLS is conducted at a number of universities in Indonesia, i.e.: Universitas Gadjah Mada Yogyakarta, Universitas Airlangga Surabaya, Universitas Atmajaya Jakarta and Universitas Indonesia with total participants of over 1,200 persons who are health practitioners, academics, researchers, and medical students.

Yogyakarta, 29 August 2015 – PT Kalbe Farma Tbk (Kalbe) in collaboration with Stem Cell and Cancer Institute (SCI) today holds the health education program for physicians, lecturers, and students of the Faculty of Medicine of Universitas Gadjah Mada. The program titled Dr.  Boenjamin Setiawan Distinguished Lecture Series holds the theme "Diagnostics and Clinical Management for colon Cancer" with keynote speakers: Ahmad Utomo PhD.  from Stem Cell and Cancer Institute, and dr. Johan Kurnianda, SpPD-KHOM from the Faculty of Medicine of Universitas Gadjah Mada, Yogyakarta.